Table 1.
Variable | Subgroup | No. of patients | % |
---|---|---|---|
Sex |
Male |
125 |
65.8 |
|
Female |
65 |
34.2 |
Age |
Median |
55 years |
|
|
Range |
(24–79 years) |
|
ECOG performance status |
0,1 |
186 |
97.9 |
|
2 |
4 |
2.1 |
Lauren |
Intestinal |
26 |
13.7 |
|
Diffuse |
41 |
21.6 |
|
Mixed |
18 |
9.5 |
|
Unknown |
105 |
55.3 |
Initial stage |
1 |
8 |
4.2 |
|
2 |
28 |
14.7 |
|
3 |
41 |
21.6 |
|
4 |
113 |
59.5 |
Operation |
+ |
127 |
66.8 |
|
- |
63 |
33.2 |
Adjuvant therapy |
+ |
79 |
41.6 |
|
- |
111 |
58.4 |
No. of metastasis |
1 |
106 |
55.8 |
|
2 |
54 |
28.4 |
|
> 3 |
30 |
15.8 |
CEA |
< 5 ng/ml |
119 |
62.6 |
|
≥ 5 ng/ml |
54 |
28.4 |
Unchecked | 17 | 8.9 |
ECOG: eastern cooperative oncology group, CEA: carcinoembryonic antigen.